| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.36B | 20.36B | 20.80B | 20.85B | 21.33B | 22.91B |
| Gross Profit | 9.54B | 14.99B | 9.71B | 13.78B | 13.80B | 15.72B |
| EBITDA | 7.36B | 7.27B | 6.46B | 7.23B | 6.88B | 7.55B |
| Net Income | 1.05B | 1.05B | 855.00M | 1.27B | 1.47B | 1.73B |
Balance Sheet | ||||||
| Total Assets | 50.98B | 50.98B | 51.74B | 49.77B | 50.88B | 53.07B |
| Cash, Cash Equivalents and Short-Term Investments | 2.81B | 2.81B | 2.31B | 3.46B | 4.65B | 6.60B |
| Total Debt | 23.33B | 23.33B | 23.48B | 21.95B | 22.84B | 25.89B |
| Total Liabilities | 38.07B | 38.07B | 39.22B | 34.48B | 39.20B | 38.30B |
| Stockholders Equity | 12.91B | 12.91B | 12.52B | 15.30B | 11.68B | 14.76B |
Cash Flow | ||||||
| Free Cash Flow | 2.05B | 2.05B | 984.00M | 1.30B | 1.06B | 2.17B |
| Operating Cash Flow | 6.99B | 6.99B | 5.95B | 5.91B | 5.96B | 6.27B |
| Investing Cash Flow | -5.01B | -5.01B | -3.54B | -3.56B | -3.24B | -5.65B |
| Financing Cash Flow | -2.11B | -2.11B | -2.43B | -2.56B | -3.22B | -807.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £20.07B | 15.39 | 5.29% | 4.42% | -2.53% | 24.52% | |
67 Neutral | £680.01M | 13.30 | 13.77% | 2.23% | 11.95% | 20.69% | |
63 Neutral | £25.56B | 7.41 | -8.37% | 3.74% | 16.15% | -279.78% | |
63 Neutral | £13.31B | 24.62 | 21.04% | 1.50% | 14.13% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | £3.90B | -16.28 | -35.13% | ― | ― | ― | |
56 Neutral | £1.85B | 58.15 | ― | ― | 4.95% | ― |